The Center of Neurotechnology and Neurorecovery (CNTR) develops, tests, and deploys novel neurotechnologies to improve the care of people suffering from diseases or injuries of the nervous system.
Established in 2009 as the Neurotechnology Trials Unit in the MGH Department of Neurology, the CNTR is dedicated to improving the care of people with diseases or injuries of the nervous system such as traumatic brain injury, spinal cord injury, stroke, epilepsy, and ALS. CNTR research and patient care benefit from a synergy of four domains of expertise:
Research and Development: Our team of clinicians, scientists and engineers works collaboratively to design new clinical neurotechnologies and perform high resolution neurophysiology research. We provide scientific expertise in the analysis and integration of complex neurophysiologic and neuroimaging data, and lead the field in research into neurologic devices, neuroprosthetics, seizure detection and prediction, disorders of consciousness, and neurorecovery.
Neurologic Device Clinical Trials: Complementing our scientific capabilities are strengths in the coordination of multi-site neurologic device clinical trials, execution of investigator-initiated and industry-sponsored clinical trials in neurologic devices, and interactions with clinical and research regulatory bodies.
Clinical Consultation: The CNTR also provides inpatient neurologic consultation for patients with severe disorders of consciousness or locked-in syndrome.
Education: The CNTR provides predoctoral and postdoctoral training in neurotechnology and neurorecovery.